Cite
HARVARD Citation
Vultaggio, A. et al. (n.d.). Circulating T cells to infliximab are detectable mainly in treated patients developing anti‐drug antibodies and hypersensitivity reactions. Clinical and experimental immunology. pp. 364-372. [Online].